Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2023-08-08 | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T.
(Chief Medical Officer) |
F | Common Stock | D | 2933 | $12.73 - $17.23 | $43,938 |
| 2024-07-11 | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T.
(Chief Medical Officer) |
S | Common Stock | D | 11945 | $15.04 - $17.08 | $190,744 |
| 2024-07-15 | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T.
(Chief Medical Officer) |
M | Common Stock | A | 5375 | $8.99 - $8.99 | $48,321 |
| 2024-06-17 | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn
(Chief Product Strategy Officer) |
S | Common Stock | D | 7266 | $12.33 - $12.33 | $89,589 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |